Literature DB >> 18835634

Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals.

Karin Pacheco1, Lisa Maier, Lori Silveira, Kelly Goelz, Kristyn Noteware, Bevin Luna, Ron du Bois, Jim Murphy, Cecile Rose.   

Abstract

BACKGROUND: Researchers and technicians working with laboratory animals (LAs) are exposed to animal allergen and endotoxin, which can interact to potentiate or inhibit symptoms or allergic responses. We hypothesized that functional genetic variants of Toll-like receptor 4 (TLR4), a key surface receptor for endotoxin, interface between worker and workplace and affect animal sensitization, symptoms, or both.
OBJECTIVE: We sought to determine whether TLR4/8551 variants alter the risk for LA sensitization, symptoms, or both.
METHODS: Three hundred thirty-five researchers, 195 of whom worked with animals, completed questions on workplace practices and symptoms and underwent skin prick tests or RASTs to common and animal allergens. Real-time PCR assessed TLR4/8551 and TLR4/8851 variants. Nominal logistic regression was used to analyze the contribution of demographic, exposure, and genetic variables to outcomes of interest.
RESULTS: Twenty-one percent of workers were LA sensitized, and 29% reported 1 or more symptoms to LAs. The TLR4/8551 G variant, which is less responsive to endotoxin, was detected in 9% and in linkage disequilibrium with the TLR4/8851 T allele. The G variant significantly associated with atopy and LA sensitization. Workers with the G variant spent significantly longer hours in high endotoxin/animal allergen tasks compared with those with the AA variant, which is perhaps less affected by endotoxin exposures. In multivariate analyses the G variant and longer animal research hours increased the risk of LA sensitization. Job tasks and LA sensitization, but not TLR4 variants, were predictors of LA-induced symptoms.
CONCLUSION: Workers with TLR4 variants that reduce responsiveness to endotoxin have higher risks for LA and other allergen sensitization but spend longer hours in tasks with high endotoxin and animal allergen exposures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835634      PMCID: PMC4347845          DOI: 10.1016/j.jaci.2008.08.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  39 in total

1.  Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals.

Authors:  D Gautrin; C Infante-Rivard; H Ghezzo; J L Malo
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide.

Authors:  M K Tulić; J L Wale; P G Holt; P D Sly
Journal:  Am J Respir Cell Mol Biol       Date:  2000-05       Impact factor: 6.914

3.  Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo.

Authors:  Neil E Alexis; John C Lay; Martha Almond; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

4.  Airways inflammation among workers in poultry houses.

Authors:  Ragnar Rylander; Maria Fernanda Carvalheiro
Journal:  Int Arch Occup Environ Health       Date:  2006-01-04       Impact factor: 3.015

5.  Airway responses in naive subjects to exposure in poultry houses: comparison between cage rearing system and alternative rearing system for laying hens.

Authors:  B M Larsson; K Larsson; P Malmberg; L Mártensson; L Palmberg
Journal:  Am J Ind Med       Date:  1999-02       Impact factor: 2.214

6.  Respiratory symptoms questionnaire for asthma epidemiology: validity and reproducibility.

Authors:  K P McKinlay; K M Venables
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

7.  Can bacterial endotoxin exposure reverse atopy and atopic disease?

Authors:  Jeroen Douwes; Graham Le Gros; Peter Gibson; Neil Pearce
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

8.  Characterization of endotoxin and mouse allergen exposures in mouse facilities and research laboratories.

Authors:  Karin A Pacheco; Charles McCammon; Peter S Thorne; Marsha E O'Neill; Andrew H Liu; John W Martyny; Michael Vandyke; Lee S Newman; Cecile S Rose
Journal:  Ann Occup Hyg       Date:  2006-05-05

9.  Airway injury in swine confinement workers.

Authors:  D A Schwartz; S K Landas; D L Lassise; L F Burmeister; G W Hunninghake; J A Merchant
Journal:  Ann Intern Med       Date:  1992-04-15       Impact factor: 25.391

10.  Occupational asthma in newly employed workers in intensive swine confinement facilities.

Authors:  J A Dosman; J A Lawson; S P Kirychuk; Y Cormier; J Biem; N Koehncke
Journal:  Eur Respir J       Date:  2004-10       Impact factor: 16.671

View more
  6 in total

Review 1.  Pathogenesis and disease mechanisms of occupational asthma.

Authors:  Zana L Lummus; Adam V Wisnewski; David I Bernstein
Journal:  Immunol Allergy Clin North Am       Date:  2011-11       Impact factor: 3.479

Review 2.  Biomarkers in Occupational Asthma.

Authors:  Javier Dominguez-Ortega; Pilar Barranco; Rosa Rodríguez-Pérez; Santiago Quirce
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

Review 3.  Laboratory Animal Allergy in the Modern Era.

Authors:  Meinir Jones
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

Review 4.  Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors:  Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

5.  Occupational asthma: etiologies and risk factors.

Authors:  Olivier Vandenplas
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-20       Impact factor: 5.764

Review 6.  Usefulness of Biomarkers in Work-Related Airway Disease.

Authors:  Agnieszka Lipińska-Ojrzanowska; Andrzej Marcinkiewicz; Jolanta Walusiak-Skorupa
Journal:  Curr Treat Options Allergy       Date:  2017-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.